Cargando…

Thyroid Dysfunction in Chinese Patients with Chronic Hepatitis C Treated with Interferon Alpha: Incidence, Long-Term Outcome and Predictive Factors

BACKGROUND: Thyroid dysfunction (TD) represents an extra-hepatic manifestation of chronic hepatitis C (CHC) and it may also be a side effect of interferon-alpha (IFN-α) based treatment. However, previous studies have shown a wide variation in the incidence of TD in patients with CHC. Furthermore, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Zehui, Fan, Ke, Fan, Yi, Wang, Xiaohong, Mao, Qing, Deng, Guohong, Wang, Yuming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475135/ https://www.ncbi.nlm.nih.gov/pubmed/23087763 http://dx.doi.org/10.5812/hepatmon.6390

Ejemplares similares

Efficacy and Safety of Low-Dose Peginterferon Alpha-2a Plus Ribavirin on Chronic Hepatitis C
por: Yan, Zehui, et al.
Publicado: (2012)

Changing Pattern of Clinical Epidemiology on Hepatitis C Virus Infection in Southwest China
por: Yan, Zehui, et al.
Publicado: (2012)

Estrogen receptor alpha gene polymorphisms and risk of HBV-related acute liver failure in the Chinese population
por: Yan, Zehui, et al.
Publicado: (2012)

Interferon-Alpha Induced and Ribavirin Induced Thyroid Dysfunction in Patients with Chronic Hepatitis C
por: Nadeem, Amina, et al.
Publicado: (2010)

Thyroid Dysfunction in Non-Interferon Treated Hepatitis C Patients Residing in Hepatitis Endemic Area
por: Batool, Nayab, et al.
Publicado: (2017)

Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
por: Rashed, Yasser K., et al.
Publicado: (2020)

Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin
por: Danilovic, Debora Lucia Seguro, et al.
Publicado: (2011)

Thyroid dysfunction can predict response to immunotherapy with interleukin-2 and interferon-2 alpha.
por: Reid, I., et al.
Publicado: (1991)

Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha
por: Liu, Yisi, et al.
Publicado: (2023)

Hepatitis B Virus Genotype B and High Expression of Interferon Alpha Receptor β Subunit are Associated With Better Response to Pegylated Interferon Alpha 2a in Chinese Patients With Chronic Hepatitis B Infection
por: Fan, He Bin, et al.
Publicado: (2012)

Association of Interferon-Alpha and Ribavirin-Induced Thyroid Dysfunction with Severity of Disease and Response to Treatment in Pakistani Asian Patients of Chronic Hepatitis C
por: Nadeem, Amina, et al.
Publicado: (2012)

Association between genetic mutations and the development of autoimmune thyroiditis in patients with chronic hepatitis C treated with interferon alpha
por: Krupińska, Janina, et al.
Publicado: (2012)

Interferon-alpha, immune activation and immune dysfunction in treated HIV infection
por: Cha, Lilian, et al.
Publicado: (2014)

B-Cell-Activating Factor Affects the Occurrence of Thyroid Autoimmunity in Chronic Hepatitis C Patients Treated with Interferon Alpha
por: Kajiyama, Yusuke, et al.
Publicado: (2012)

A Potential Functional Cure in Chinese HBeAg-negative Chronic Hepatitis B Patients Treated with Peg-interferon Alpha-2a
por: Chen, Xinyue, et al.
Publicado: (2019)

Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B
por: Zhang, Wenhong, et al.
Publicado: (2018)

The spectrum of thyroid dysfunction in an Australian hepatitis C population treated with combination Interferon-α2β and Ribavirin
por: Tran, Huy A, et al.
Publicado: (2005)

Incidence of retinopathy in chronic hepatitis C patients treated with pegylated interferon alpha 2a and ribavirin combination therapy
por: Kashif, Muhammad, et al.
Publicado: (2015)

Interferon-alpha responsible EPN3 regulates hepatitis B virus replication
por: Li, Xueqian, et al.
Publicado: (2022)

Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report
por: Gill, Gurmit, et al.
Publicado: (2016)

Frequency of Thyroid Dysfunctions during Interferon Alpha Treatment of Single and Combination Therapy in Hepatitis C Virus-Infected Patients: A Systematic Review Based Analysis
por: Nair Kesavachandran, Chandrasekharan, et al.
Publicado: (2013)

Interferon-alpha-induced sarcoidosis in a patient being treated for hepatitis C
por: Trien, Remi, et al.
Publicado: (2014)

Thyroiditis after treatment with interleukin-2 and interferon alpha-2a.
por: Pichert, G., et al.
Publicado: (1990)

Clinical Utility of Serum Interleukin-8 and Interferon-Alpha in Thyroid Diseases
por: Kobawala, Toral P., et al.
Publicado: (2011)

‘Double-hit’ pegylated interferon-alpha successfully treats Hepatitis B and Hepatitis D co-infection
por: Bhuva, Meha, et al.
Publicado: (2020)

Thyroid dysfunction is associated with the loss of hepatitis B surface antigen in patients with chronic hepatitis B undergoing treatment with α-interferon
por: Luo, Wenfan, et al.
Publicado: (2021)

A Missense Variant in Granulysin is Associated with the Efficacy of Pegylated-Interferon-Alpha Therapy in Chinese Patients with HBeAg-Positive Chronic Hepatitis B
por: Li, Jing, et al.
Publicado: (2021)

Thyroid Peroxidase Antibodies in Non-Interferon Treated Hepatitis C Patients in Pakistan
por: Shafiq, Muhammad Imtiaz, et al.
Publicado: (2015)

Interferon Alpha-2b Therapy in Chronic Hepatitis Delta
por: Keshvari, Maryam, et al.
Publicado: (2014)

Pegylated Interferon Alpha for Chronic Hepatitis B Virus Infection
por: Vasconcelos, Joana, et al.
Publicado: (2022)

Effects of Interferon-Alpha Treatment on the Incidence of Hyperglycemia in Chronic Hepatitis C Patients: A Systematic Review and Meta-Analysis
por: Zhang, Wei, et al.
Publicado: (2012)

Interleukin‐2 promotes pegylated interferon alpha for hepatitis B surface antigen loss: A retrospective pragmatic clinical study at the Fourth Affiliated Hospital of Zhejiang University Medical College
por: Qi, Wencai, et al.
Publicado: (2022)

Interferon Alpha Induces Cellular Autophagy and Modulates Hepatitis B Virus Replication
por: Li, Jia, et al.
Publicado: (2022)

Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha
por: Scagnolari, Carolina, et al.
Publicado: (2010)

Interferon-Alpha-Induced Destructive Thyroiditis Followed by Graves' Disease in a Patient with Chronic Hepatitis C: A Case Report
por: Kim, Bu Kyung, et al.
Publicado: (2011)

Efficacy and safety of interferon alpha therapy in children with chronic hepatitis B: A long-term follow-up cohort study from China
por: Hu, Yao, et al.
Publicado: (2019)

Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment
por: Giersch, Katja, et al.
Publicado: (2023)

Hashimoto's Thyroiditis and Graves' Disease in One Patient: The Extremes of Thyroid Dysfunction Associated with Interferon Treatment
por: Bishay, R. H., et al.
Publicado: (2016)

High Incidence of Thyroid Dysfunction in Preterm Infants
por: Chung, Hye Rim, et al.
Publicado: (2009)

Exosomal Interferon‐Induced Transmembrane Protein 2 Transmitted to Dendritic Cells Inhibits Interferon Alpha Pathway Activation and Blocks Anti–Hepatitis B Virus Efficacy of Exogenous Interferon Alpha
por: Shi, Ying, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bptcnsrn37bvulgc93e7obhgqn